[1]
|
D. L. Knobel, S. Cleveland, P. G. Coleman, E. M. Fèvre, M. I. Meltzer, et al., “Re-Evaluating the Burden of Rabies in Africa and Asia,” Bulletin of the World Health Organization, Vol. 83, No. 5, 2005, pp. 360-368.
|
[2]
|
M. K. Sudershan, “Assessing Burden of Rabies in India WHO Sponsored National Multi-Centric Survey 2003,” Association for Prevention and Control of Rabies in India, AMS Code 1079420, 2004.
|
[3]
|
T. Burki, “The Global Fight against Rabies,” The Lancet, Vol. 372, No. 9644, 2008, pp. 1135-1136.
doi:10.1016/S0140-6736(08)61462-2
|
[4]
|
World Health Organization, “WHO Expert Consultation on Rabies: First Report,” World Health Organization, Geneva, 2005 (WHO Technical Report Series, No. 931).
|
[5]
|
S. D. Semple, “Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India,” No. 44, New Series, Calcutta, 1911.
|
[6]
|
S. Madhusudana, “Rabies,” Mc Millan Medical Communications, Gurgaon, 2011, p. 151.
|
[7]
|
Average Prices in India 2010 as reference.
|
[8]
|
World Health Organization, “WHO Expert Committee on Rabies, 8th Report,” World Health Organization, Geneva, 1992.
|
[9]
|
S. Madhusudana, “Rabies,” Mc Millan Medical Communications, Gurgaon, 2011, p. 150.
|
[10]
|
Departmental Communication from Chief Medical Officer, Unpublished Document, Hamirpur, 2009.
|
[11]
|
“Multicentric Study on the Use of Intradermal Administration of Tissue Culture Antirabies Vaccines in India,” Web Document, pp. 12-15.
http://icmr.nic.in/annual/2004-05/nie/clinical_trials.pdf
|
[12]
|
Rabipur, Virorab and Indirab Brands in India Allow Intra-Dermal Use Apart from Intramuscular Use and Write “For IM/ID Use”.
|
[13]
|
M. J. Warrell, A. Riddell, L.-M. Yu, J. Phipps, L. Diggle, et al., “A Simplified 4-Site Economical Intradermal Post-Exposure Rabies Vaccine Regimen: A Randomised Controlled Comparison with Standard Methods,” PLoS Neglected Tropical Diseases, Vol. 2, No. 4, 2008, p. e224.
doi:210.1371/journal.pntd.0000224
|
[14]
|
CDC, “Mass Treatment of Humans Who Drank Unpasteurized Milk from Rabid Cows—Massachusetts, 1996-1998,” MMWR Weekly, Vol. 48, No. 11, 1999, pp. 228-229.
|
[15]
|
PATH, “Intradermal Delivery of Vaccines: A Review of the Literature and Potential for Development for Use in Low- and Middle-Income Countries,” Program for Appropriate Technology in Health (PATH), Seattle, 2009.
|
[16]
|
J. K. Hickling, K. R. Jones, M. Friede, D. Zehrung, D. Chen and D. Kristensen, “Intradermal Delivery of Vaccines: Potential Benefits and Current Challenges,” Bulletin of the World Health Organization, Vol. 89, 2011, pp. 221-226. doi:10.2471/BLT.10.079426
|